Henry Kay

Henry Kay is currently a Director at Cannuflow, Inc., Avaxia Biologics, Inc., Cristcot, Inc., CoolSystems, Inc., CellAegis Devices, Inc., Cristcot LLC, and Sky Ventures International LLC.
He previously worked as a Director at Microfluidics International Corp., SmartCells, Inc., Myomo, Inc., and Jewish Family & Children's Service, Inc. He was also a Director at Wadsworth Medical Technologies, Inc. from 2006 to 2013.
Additionally, he was a Senior Vice President-Sales & Marketing at Allergan, Inc. and a VP-New Market Development & Strategic Planning at Boston Scientific Corp.
from 1996 to 2006.
He was a Partner at Medica Venture Partners from 2008 to 2014 and an Advisor at Quantum Dental Technologies, Inc. from 2008 to 2011.
He has an undergraduate degree from Augusta State University, a graduate degree from Rutgers State University of New Jersey, and an MBA from Seton Hall University.